Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway

Zineb Mounir1, Jothi Latha Krishnamoorthy, Gavin P Robertson

  • 1Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada.

Science Signaling
|December 24, 2009
PubMed

Insights

Tumor suppressor PTEN regulates protein synthesis inhibition via eukaryotic translation initiation factor 2 alpha (eIF2α) phosphorylation. This pathway, involving RNA-dependent protein kinase (PKR), is crucial for PTEN

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • Protein synthesis is regulated by eIF2α phosphorylation, a stress response.
  • RNA-dependent protein kinase (PKR) mediates proapoptotic eIF2α phosphorylation.
  • PTEN is a tumor suppressor with diverse functions, often lost in cancer.

Purpose of the Study:

  • To investigate the role of PTEN in regulating eIF2α phosphorylation.
  • To determine if PTEN's tumor suppressive functions are linked to protein synthesis inhibition.
  • To elucidate the specific pathways downstream of PTEN involved in eIF2α phosphorylation.

Main Methods:

  • Utilized human melanoma, glioblastoma, and prostate cancer cell lines.
  • Assessed eIF2α phosphorylation levels following PTEN manipulation (inactivation/reconstitution).
  • Employed PKR-deficient and eIF2α phosphorylation-defective mouse embryonic fibroblasts.

Main Results:

  • PTEN inactivation reduced eIF2α phosphorylation; PTEN reconstitution induced it.
  • PTEN's antiproliferative and proapoptotic effects were dependent on PKR and eIF2α phosphorylation.
  • PTEN's PDZ-binding motif was essential for inducing the eIF2α phosphorylation pathway.

Conclusions:

  • PTEN directly regulates the eIF2α phosphorylation pathway, impacting protein synthesis.
  • This PTEN-mediated inhibition of protein synthesis is independent of PI3K signaling.
  • The findings link PTEN's tumor suppressor activity to the control of protein synthesis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...